News

Hot flashes linked to increased hip fracture risk


 

FROM THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM

References

Hot flashes are associated with a significant increase in the risk of hip fracture, regardless of age, body mass index, and other confounders such as smoking, according to analysis of data from the Women’s Health Study.

The prospective, observational study among 4,867 women aged 50-79 years found a 78% increase in the risk of hip fracture among women with moderate to severe menopausal vasomotor symptoms at baseline, compared with women with no symptoms.

Dr. Carolyn J. Crandall

Dr. Carolyn J. Crandall

Vasomotor symptom severity was also inversely associated with bone mineral density (BMD) at both the femoral neck and the spine. Compared with women who had no vasomotor symptoms, those with moderate or severe symptoms had 0.015 g/cm2 lower femoral neck BMD and 0.016 g/cm2 lower lumbar spine BMD, according to an analysis published on Dec. 18 in the Journal of Clinical Endocrinology and Metabolism (2014 [doi:10.1210/jc.2014-3062]).

“Despite being younger and heavier than asymptomatic women, characteristics associated with higher BMD, women with moderate/severe [vasomotor symptoms] had a higher risk of hip fractures that was also independent of other established risk factors for fractures,” wrote Dr. Carolyn J. Crandall of the University of California, Los Angeles, and her colleagues.

The study was funded by the National Institutes of Health. Two of the study authors reported consulting and other financial relationships with drug and device companies.

Recommended Reading

VIDEO: Causes of low libido in postmenopausal women are complex, don’t always require pharmacologic treatment
MDedge Family Medicine
VIDEO: Novel and other therapies for vaginal dryness
MDedge Family Medicine
Purified pollen extract for hot flashes did not inhibit tamoxifen’s efficacy
MDedge Family Medicine
Ovarian aging may be tip-off for cardiovascular risk
MDedge Family Medicine
VIDEO: SERMs move beyond osteoporosis, breast cancer prevention
MDedge Family Medicine
Soy isoflavones safe in postmenopausal women, data from 3-year trial showed
MDedge Family Medicine
Ospemifene’s effect more comprehensive than its FDA indication
MDedge Family Medicine
New use for old DXA scanners?
MDedge Family Medicine
Osteoporosis medication use down in older women
MDedge Family Medicine
Hormone therapy ‘timing hypothesis’ gains ground in ELITE
MDedge Family Medicine